phase readout
saveNCT05966467: Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
RECRUITINGupdated 4d ago
community read0 votes
Sponsor: Alexion Pharmaceuticals, Inc.. Phase: . Conditions: Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD
view source ↗
comments(0)
5-min edit window · permanent after that